The Novel Modified Cattell-Warren Duct-To-Mucosa Pancreaticojejunostomy Technique Significantly Reduces POPF.
POPF
Duct To Mucosa Pancreaticojejunostomy (The Novel Modified Cattell Warren Technique) Significantly Reduces POPF: A Single-Center Experience
1 other identifier
observational
27
1 country
1
Brief Summary
Pancreatic surgeries, such as pancreaticoduodenectomy and distal pancreatectomy, are associated with high morbidity and mortality. The most common cause of this morbidity is postoperative pancreatic fistula(POPF). The risk of POPF depends on the texture of pancreatic parenchyma, the size of the main pancreatic duct, and the technique of pancreatic-enteric reconstruction. There are several techniques for pancreaticojejunostomy anastomosis. Among which duct to mucosa is considered a relatively safe anastomosis technique. However, there are several modifications to the duct-to-mucosa technique. The investigators of this study believe that the modified Cattell-Warren duct-to-mucosa technique, which includes taking more than 5 mm of periductal pancreatic parenchyma with the duct and the full-thickness jejunum while performing pancreaticojejunostomy reconstruction with proper perioperative nutritional optimization and prehabilitation, improves patient outcomes. So the investigators aim to assess the risk of POPF in the novel modified Cattell-Warren technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2025
CompletedFirst Submitted
Initial submission to the registry
June 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2025
CompletedFirst Posted
Study publicly available on registry
June 26, 2025
CompletedJune 26, 2025
June 1, 2025
2.2 years
June 9, 2025
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with clinically relevant postoperative pancreatic fistula
To assess the rate of clinically relevant postoperative pancreatic fistula (CR POPF) in the standard time frame as per ISGPS guidelines.
Assessed between postoperative day 3 and up to 30 days
Secondary Outcomes (3)
Number of patients with other postoperative complications based on the Clavien-Dindo Classification grading
up to 90 postoperative days and during follow-up in OPD (as per departmental protocol for this study)
Length of hospital stay
Length of hospital stay (LOS) was defined as the time (in days) from the date of surgery to the date of hospital discharge, assessed up to 90 days postoperatively.
Mortality
up to 30 postoperative days or till the date of in-hospital mortality due to any cause, assessed upto 30 postoperative days
Study Arms (1)
Modified Cattell-Warren Technique for Pancreaticojejunostomy
All patients undergoing the duct-to-mucosa (the Modified Cattell-Warren technique) for pancreaticojejunostomy in the Pancreaticoduodenectomy and Distal Pancreatectomy.
Interventions
Technical modification of the original Cattell-Warren technique in all the stitches of both posterior and anterior duct-to-mucosa layer, taking the pancreatic duct with more than 5mm of pancreatic parenchyma adjacent to the duct and towards the jejunal side, taking more than 5 mm of full-thickness jejunum including mucosa.
Routine perioperative incentive spirometry, four extremities exercise, and nutritional optimization with albumin and Total Parenteral Nutrition
Eligibility Criteria
All patients undergoing the modified Cattell-Warren duct-to-mucosa pancreaticojejunostomy technique in the pancreaticoduodenectomy or distal pancreatectomy in the department of Surgical Gastroenterology in the Nepal Medical College and Teaching Hospital.
You may qualify if:
- Patient undergoing duct to mucosa PJ (the modified Cattell Warren technique) in pancreatic surgery for presumed or diagnosed malignancy of the head of the pancreas and periampullary carcinoma.
- Patient undergoing distal pancreatectomy for presumed or diagnosed malignancy or cystic neoplasm of the pancreas involving the body and tail.
- Age \> 18 years
You may not qualify if:
- Other techniques of reconstruction like Dunking, Blumgart's, and binding technique.
- Patient with previous pancreatic resection for any etiology
- Patient undergoing extended pancreaticoduodenectomy
- Arterial resection or divestment
- Multi-visceral resection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gonish Hada
Kathmandu, Bagmati, 00977, Nepal
Related Publications (4)
Sun Y, Yu XF, Yao H, Xu S, Ma YQ, Chai C. Safety and feasibility of modified duct-to-mucosa pancreaticojejunostomy during pancreatoduodenectomy: A retrospective cohort study. World J Gastrointest Surg. 2023 Sep 27;15(9):1901-1909. doi: 10.4240/wjgs.v15.i9.1901.
PMID: 37901736BACKGROUNDSun X, Zhang Q, Zhang J, Lou Y, Fu Q, Zhang X, Liang T, Bai X. Meta-analysis of invagination and duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: An update. Int J Surg. 2016 Dec;36(Pt A):240-247. doi: 10.1016/j.ijsu.2016.11.008. Epub 2016 Nov 5.
PMID: 27826046BACKGROUNDHai H, Li Z, Zhang Z, Cheng Y, Liu Z, Gong J, Deng Y. Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy. Cochrane Database Syst Rev. 2022 Mar 15;3(3):CD013462. doi: 10.1002/14651858.CD013462.pub2.
PMID: 35289922BACKGROUNDHao X, Li Y, Liu L, Bai J, Liu J, Jiang C, Zheng L. Is duct-to-mucosa pancreaticojejunostomy necessary after pancreaticoduodenectomy: A meta-analysis of randomized controlled trials. Heliyon. 2024 Jun 15;10(13):e33156. doi: 10.1016/j.heliyon.2024.e33156. eCollection 2024 Jul 15.
PMID: 39040391BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Nabin Pokharel, MBBBS,MS,MCh
Nepal Medical College and Teaching Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Official Title: Prof Dr. Nabin Pokharel, Head of Department of Surgical Gastroenterology Affiliation: Nepal Medical College and Teaching Hospital
Study Record Dates
First Submitted
June 9, 2025
First Posted
June 26, 2025
Study Start
April 1, 2023
Primary Completion
June 4, 2025
Study Completion
June 9, 2025
Last Updated
June 26, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share